Press releaseGlobe Newswire
Tevogen Bio Holdings
TVGN · NASDAQ
$6.82+$0.05 (+0.74%)TodayMarket closed ·
Prev close $6.77
Latest news
- Press releaseGlobe Newswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
- Press releaseGlobe Newswire
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
- Press releaseGlobe Newswire
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
- Press releaseGlobe Newswire
Tevogen Announces Formation of a Healthcare Services Initiative
- Press releaseGlobe Newswire
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
- Press releaseGlobe Newswire
Letter to Shareholders from CEO Dr. Ryan Saadi
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
- Press releaseGlobe Newswire
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
- Press releaseGlobe Newswire
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
- Press releaseGlobe Newswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
- Press releaseGlobe Newswire
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
- News
Tevogen Evaluates Potential One-Time Special Cash Dividend, Subject To Future Financial Milestones
- Press releaseGlobe Newswire
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
- Press releaseGlobe Newswire
Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID
- Press releasePRNewswire
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction
- Press releasePRNewswire
From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine
- Press releasePRNewswire
AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway
- Press releasePRNewswire
AI Healthcare Boom Gains Speed as Regulators and Innovators Align
- NewsAvi Kapoor
Why Leggett & Platt Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- NewsAdam Eckert
Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On?
- Press releasePRNewswire
WHO and WEF Are Pushing AI in Global Healthcare -- What It Means for the Market
- NewsRishabh Mishra
US Stock Futures Tumble As DeepSeek Buzz Jolts Big Tech: Expert Says The Chinese AI Model Is Yet To Prove Its Viability At Lower Cost In Long Term
- Press releaseGlobe Newswire
Tevogen Bio Prepares Organizational Readiness to Support Company's Growth Strategy
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
- NewsVaishali Prayag
Tevogen Bio Shares Are On The Rise Monday: What's Going On?
- NewsChris Katje
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
- NewsAvi Kapoor
Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- NewsAvi Kapoor
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump
- NewsAvi Kapoor
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher
- NewsAvi Kapoor
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction
- NewsAvi Kapoor
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Tevogen Bio Secures $6 Million Series C Preferred Stock Investment
- Press releaseGlobe Newswire
Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company's Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.